We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




CT Clues Offer New Diagnostic Criteria for Chest Tumors

By HospiMedica International staff writers
Posted on 06 Sep 2015
The results of a recent study are providing new diagnostic criteria to help clinicians diagnose mediastinal masses in children, and differentiate between a fungal infection histoplasmosis, and cancer.

Until now no one symptom, test or CT imaging exam has been able to distinguish between benign and cancerous masses, and this often resulted in unnecessary biopsies. More...
The study was led by researchers from St. Jude Children’s Research Hospital (Memphis, TN, USA) and was published in the July 22, 2015, issue of the Journal of Pediatrics.

The researchers analyzed symptoms, Computed Tomography (CT) scans, and laboratory tests of 131 children with chest masses, and were able to diagnose cancers earlier and reduce the need for biopsies. Symptoms included fever, night sweats, weight loss, cough, chest pain, headaches, swelling of the neck, and physical discomfort. Laboratory tests included blood tests, and CT exams included evidence of enlarged lymph nodes and chest masses. The researchers found that in 104 children, the chest masses were benign.

Elisabeth Adderson, MD, the lead researcher, said, “The problem has been that there are both benign and malignant causes of mediastinal masses. Sometimes the malignant masses are rapidly progressive and life-threatening, and therefore it is important to make a prompt diagnosis. In contrast, the benign causes, principally the fungus histoplasmosis, are often self-limiting or respond to drugs. Like previous investigators, we found that there was no single clinical, laboratory or radiologic feature that was good enough by itself to distinguish malignant from benign masses. But the unique feature that we identified, not previously recognized, was that the presence of lymphopenia and of enlarged cervical lymph nodes on CT scans was more suggestive of a malignant diagnosis.”

Related Links:

St. Jude Children’s Research Hospital



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Spirometry & Oximetry Software
MIR Spiro
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.